Berg K. A new serum type system in man - the Lp system. Acta Path Microbiol Scand. 1963;59:369–82.

Article  CAS  PubMed  Google Scholar 

Dahlen G. The pre-beta1 lipoprotein phenomenon in relation to serum cholesterol and triglyceride levels, the Lp(a) lipoprotein and coronary heart disease. Acta Med Scand. 1974;Suppl. 570:1–45.

Google Scholar 

Frick MH, Dahlén G, Furbery C, Ericson C, Wiljasalo M. Serum pre-beta-1 lipoprotein fraction in coronary atherosclerosis. Acta Med Scand. 1974;195(5):337–40. https://doi.org/10.1111/j.0954-6820.1974.tb08149.x.

Article  CAS  PubMed  Google Scholar 

Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis. 1981;38:51–61.

Article  CAS  PubMed  Google Scholar 

Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925–46. https://doi.org/10.1093/eurheartj/ehac361. This is the most recent EAS consensus statement on Lp(a) which updates evidence for the role of Lp(a) in atherosclerotic cardiovascular disease and aortic valve stenosis, provides clinical guidance for testing and treating elevated Lp(a) levels, and considers its inclusion in global risk estimation.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, et al. Lp(a) (lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank. Arterioscler Thromb Vasc Biol. 2021;41:465–74. https://doi.org/10.1161/ATVBAHA.120.315291.

Article  CAS  PubMed  Google Scholar 

Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, et al. Lipoprotein(a) and ethnicities. Atherosclerosis. 2022;349:42–52. https://doi.org/10.1016/j.atherosclerosis.2022.04.005.

Article  CAS  PubMed  Google Scholar 

• Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023;374:107–20. https://doi.org/10.1016/j.atherosclerosis.2023.04.012. This paper is considered as a follow-up paper on the EAS consensus statement on Lp(a) that answers 30 frequently asked questions about Lp(a) epidemiology, its contribution to cardiovascular risk, Lp(a) measurement, risk factor management and existing therapeutic options.

Article  CAS  PubMed  Google Scholar 

Koschinsky ML, Stroes ESG, Kronenberg F. Daring to dream: targeting lipoprotein(a) as a causal and risk-enhancing factor. Pharmacol Res. 2023;194:106843. https://doi.org/10.1016/j.phrs.2023.106843.

Article  PubMed  Google Scholar 

Koschinsky ML, Kronenberg F. The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target. Atherosclerosis. 2022;349:1–6. https://doi.org/10.1016/j.atherosclerosis.2022.04.017.

Article  CAS  PubMed  Google Scholar 

•• Arsenault BJ, Kamstrup PR. Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective. Atherosclerosis. 2022;349:7–16. https://doi.org/10.1016/j.atherosclerosis.2022.04.015. This review provides a comprehensive overview on the evidence from the largest and most informative genetic association studies and prospective studies that have investigated the association between Lp(a) and human lifespan, healthspan, cardiovascular disease, calcific aortic valve stenosis and non-cardiovascular diseases.

Article  CAS  PubMed  Google Scholar 

Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80:458–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 1990;29:640–4.

Article  CAS  PubMed  Google Scholar 

Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991;87:2153–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kraft HG, Köchl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet. 1992;90:220–30.

Article  CAS  PubMed  Google Scholar 

Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Császár A, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 1991;86:607–14.

Article  CAS  PubMed  Google Scholar 

Laschkolnig A, Kollerits B, Lamina C, Meisinger C, Rantner B, Stadler M, et al. Lipoprotein(a) concentrations, apolipoprotein(a) phenotypes and peripheral arterial disease in three independent cohorts. Cardiovasc Res. 2014;103(1):28–36. https://doi.org/10.1093/cvr/cvu107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kronenberg F, Utermann G. Lipoprotein(a) - resurrected by genetics. J Intern Med. 2013;273(1):6–30. https://doi.org/10.1111/j.1365-2796.2012.02592.x.

Article  CAS  PubMed  Google Scholar 

White AL, Hixson JE, Rainwater DL, Lanford RE. Molecular basis for null lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J Biol Chem. 1994;269:9060–6.

Article  CAS  PubMed  Google Scholar 

Brunner C, Lobentanz EM, Pethö-Schramm A, Ernst A, Kang C, Dieplinger H, et al. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem. 1996;271:32403–10.

Article  CAS  PubMed  Google Scholar 

Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perombelon YFN, Soutar AK, Knight BL. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest. 1994;93:1481–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518–28.

Article  CAS  PubMed  Google Scholar 

Kronenberg F. Genetic determination of lipoprotein(a) and its association with cardiovascular disease. Convenient does not always mean better. J Intern Med. 2014;276:243–7. https://doi.org/10.1111/joim.12207.

Article  CAS  PubMed  Google Scholar 

Mack S, Coassin S, Rueedi R, Yousri NA, Seppala I, Gieger C, et al. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms. J Lipid Res. 2017;58(9):1834–44. https://doi.org/10.1194/jlr.M076232.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Said MA, Yeung MW, van de Vegte YJ, Benjamins JW, Dullaart RPF, Ruotsalainen S, et al. Genome-wide association study and identification of a protective missense variant on lipoprotein(a) concentration: protective missense variant on lipoprotein(a) concentration-Brief Report. Arterioscler Thromb Vasc Biol. 2021;41(5):1792–800. https://doi.org/10.1161/ATVBAHA.120.315300.

Article  CAS  PubMed  Google Scholar 

•• Coassin S, Kronenberg F. Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene. Atherosclerosis. 2022;349:17–35. https://doi.org/10.1016/j.atherosclerosis.2022.04.003. This review provides a comprehensive overview on the complex genetic architecture of the Lp(a) concentrations in plasma. Understanding the genetics of Lp(a) boosters new ideas on the metabolism of Lp(a) and possible interventional targets.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coassin S, Erhart G, Weissensteiner H, de Araujo MEG, Lamina C, Schönherr S, et al. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction. Eur Heart J. 2017;38(23):1823–31. https://doi.org/10.1093/eurheartj/ehx174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Schachtl-Riess JF, Kheirkhah A, Grüneis R, Di Maio S, Schoenherr S, Streiter G, et al. Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease. J Am Coll Cardiol. 2021;78(5):437–49. https://doi.org/10.1016/j.jacc.2021.05.037. This paper identified two of the most important genetic variants in the K-IV type-2 region of the LPA gene with a pronounced influence on Lp(a) concentrations and also cardiovascular risk.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamina C. Mendelian randomization: principles and its usage in Lp(a) research. Atherosclerosis. 2022;349:36–41. https://doi.org/10.1016/j.atherosclerosis.2022.04.013.

Article  CAS  PubMed  Google Scholar 

Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992;89:1040–6.

Article  CAS  PubMed